Key facts
- This page summarizes William P. Forbes's Form 4 filing for HERON THERAPEUTICS, INC. /DE/ (HRTX).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 04 Feb 2025, 12:44.
William P. Forbes - 31 Jan 2025 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)
- Reporting relationship
- EVP, Chief Development Officer
- Issuer ticker
- HRTX
- Reported as of
- 31 Jan 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 04 Feb 2025, 12:44:33 UTC
- Prior SEC filing
- 22 Jan 2025
- Next SEC filing
- 28 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/Kathryn Lester Attorney-in-fact for William P. Forbes
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
William P. Forbes filed Form 4 for HERON THERAPEUTICS, INC. /DE/ (HRTX) on 04 Feb 2025.
Change
- Previous filing in this sequence was filed on 22 Jan 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HRTX
transaction
Derivative
Employee Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +374,220
- Change %
- Price
- $0.000000
- Shares after
- 374,220
- Date
- 31 Jan 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 374,220
- Exercise price
- $1.70
- Footnotes
- F1
HRTX
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +187,110
- Change %
- Price
- $0.000000
- Shares after
- 187,110
- Date
- 31 Jan 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 187,110
- Exercise price
- $0.000000
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (January 31, 2025).
Footnote F2
The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025).